FRANKFURT — Swiss drugmaker Roche (ROG.S), said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that causes serious hospital infections into the ...

Associated with more than 559,000 deaths globally per year, this drug-resistant bug is, according to the Center for Disease Control and Prevention, believed to cause other illnesses like pneumonia ...

A new antibiotic that has the potential to save millions of lives has entered its last phase of human testing. The antibiotic zosurabalpin, which is jointly developed with Harvard University, is ...

Associated with more than 559,000 deaths globally per year, this drug-resistant bug is, according to the Center for Disease Control and Prevention, believed to cause other illnesses like pneumonia or ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

The drug Zosurabalpin, is being developed to target one of the bacteria considered to pose the biggest threat to human health. Swiss pharmaceutical giant Roche has announced it is taking the drug into ...